TGFB1 and ovarian serous adenocarcinoma: Further exploring the signaling pathways in tumors, ssGSEA analysis showed that while SLC7A1 was highly expressed in patients with serous ovarian cancer, TGF‐β and EMT pathways were significantly enriched (p < 0.05) (Figure 4D).